Anneleen Lintermans
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Tamoxifen Metabolism and Efficacy in Breast Cancer: A Prospective Multicenter Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 13, 2017
Associations Between Patient and Anthropometric Characteristics and Aromatase Inhibitor Discontinuation.
Journal: Clinical breast cancer
Published: November 17, 2016
Genetic variant in the osteoprotegerin gene is associated with aromatase inhibitor-related musculoskeletal toxicity in breast cancer patients.
Journal: European journal of cancer (Oxford, England : 1990)
Published: July 13, 2015
Safety of aromatase inhibitor therapy in breast cancer.
Journal: Expert opinion on drug safety
Published: June 11, 2015
The UZ Leuven Policy for Extended Adjuvant Anti-estrogen Therapy in Women With Early Estrogen Receptor-Positive Breast Cancer.
Journal: Current treatment options in oncology
Published: June 03, 2015
Vaginal estriol-lactobacilli combination and quality of life in endocrine-treated breast cancer.
Journal: Climacteric : the journal of the International Menopause Society
Published: November 28, 2014
Arthralgia induced by endocrine treatment for breast cancer: A prospective study of serum levels of insulin like growth factor-I, its binding protein and oestrogens.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 28, 2014
A prospective assessment of musculoskeletal toxicity and loss of grip strength in breast cancer patients receiving adjuvant aromatase inhibitors and tamoxifen, and relation with BMI.
Journal: Breast cancer research and treatment
Published: April 24, 2014
Aromatase inhibitors in the breast cancer clinic: focus on exemestane.
Journal: Endocrine-related cancer
Published: January 18, 2014
Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
Journal: Breast cancer research and treatment
Published: December 03, 2013
Sensitive routine liquid chromatography-tandem mass spectrometry method for serum estradiol and estrone without derivatization.
Journal: Analytical and bioanalytical chemistry
Published: April 22, 2013
Need for estradiol assays with a lower functional sensitivity in clinical studies examining postmenopausal women treated with aromatase inhibitors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 28, 2012
Last Updated: 09/26/2026